Phospholipid scramblase 1 expression is enhanced in patients with antiphospholipid syndrome (Q39360288)

11 September 2017

title

Phospholipid scramblase 1 expression is enhanced in patients with antiphospholipid syndrome (English)

1 reference

11 September 2017

7

Takao Koike

1 reference

11 September 2017

Olga Amengual

1

1 reference

11 September 2017

Tatsuya Atsumi

2

1 reference

11 September 2017

Kenji Oku

3

1 reference

11 September 2017

Eriko Suzuki

4

1 reference

11 September 2017

Tetsuya Horita

5

1 reference

11 September 2017

Shinsuke Yasuda

6

1 reference

11 September 2017

publication date

24 April 2012

1 reference

11 September 2017

1 reference

11 September 2017

volume

23

1 reference

11 September 2017

issue

1

1 reference

11 September 2017

page(s)

81-88

1 reference

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0642-9

Increased expression of phospholipid scramblase 1 in monocytes from patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0642-9

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0642-9

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0642-9

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0642-9

Lipid translocation across the plasma membrane of mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0642-9

21 January 2018

Phospholipid flippases

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0642-9

Pathogenesis of antiphospholipid syndrome: understanding the antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0642-9

Calcium-dependent phospholipid scrambling by TMEM16F

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0642-9

Interferon-alpha-induced expression of phospholipid scramblase 1 through STAT1 requires the sequential activation of protein kinase Cdelta and JNK.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0642-9

Plasma membrane phospholipid scramblase 1 promotes EGF-dependent activation of c-Src through the epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0642-9

Protein kinase Cdelta mediates retinoic acid and phorbol myristate acetate-induced phospholipid scramblase 1 gene expression: its role in leukemic cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0642-9

Normal hemostasis but defective hematopoietic response to growth factors in mice deficient in phospholipid scramblase 1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0642-9

Thrombosis in primary antiphospholipid syndrome: a pivotal role for monocyte tissue factor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0642-9

10.3109/S10165-012-0642-9

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference